Read More Pharma Industry News Eli Lilly’s tirzepatide shows promising results for obstructive sleep apnea in latest clinical trials Eli Lilly and Company (NYSE: LLY) has announced promising results from the SURMOUNT-OSA phase 3 clinical trials of… byPallavi MadhirajuJune 24, 2024